Colorectal cancer deaths attributable to nonuse of screening in the United States

Annals of Epidemiology

Volumn 25, Issue 3, 2015, Pages 208-213.e1

  Meester, Reinier G S ^a   Doubeni, Chyke A ^b   Lansdorp Vogelaar, Iris ^a   Goede, S Lucas ^a   Levin, Theodore R ^c   Quinn, Virginia P ^d   van Ballegooijen, Marjolein ^a   Corley, Douglas A ^c   Zauber, Ann G ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d KAISER PERMANENTE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adenomas; Adenomatous polyps; Colorectal neoplasms; Computer simulation; Epidemiology; Screening and early detection; Secondary prevention

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CAUSAL ATTRIBUTION; COLONOSCOPY; COLORECTAL CANCER; COMPUTER SIMULATION; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OCCULT BLOOD TEST; POPULATION ATTRIBUTABLE FRACTION; PRECANCER; PRIORITY JOURNAL; SCREENING TEST; SECONDARY PREVENTION; SIGMOIDOSCOPY; UNITED STATES; VERY ELDERLY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; INCIDENCE; MALE; MASS SCREENING; MORTALITY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UTILIZATION;

AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; TIME FACTORS; UNITED STATES;

EID: 84923248173     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2014.11.011     Document Type: Article

References (48)

1. Siegel R., Desantis C., Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014, 64(2):104-117.
2. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010, 19(8):1893-1907.
3. Yang D.X., Gross C.P., Soulos P.R., Yu J.B. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer 2014, 120(18):2893-2901.
4. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010, 116(3):544-573.
5. Centers for Disease Control and Prevention. Colorectal Cancer Awareness. Available from: [accessed May 2014]. http://www.cdc.gov/cancer/dcpc/resources/features/colorectalawareness/.
6. Levin M.L. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953, 9(3):531-541.
7. Stock C., Knudsen A.B., Lansdorp-Vogelaar I., Haug U., Brenner H. Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc 2011, 73(3):435-443.e5.
8. Hilsden R.J. Quantifying the benefit of screening colonoscopy. Gastrointest Endosc 2011, 73(3):444-446.
9. Muller A.D., Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995, 155(16):1741-1748.
10. Baxter N.N., Goldwasser M.A., Paszat L.F., Saskin R., Urbach D.R., Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150(1):1-8.
11. Klabunde C.N., Cronin K.A., Breen N., Waldron W.R., Ambs A.H., Nadel M.R. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011, 20(8):1611-1621.
12. Shapiro J.A., Klabunde C.N., Thompson T.D., Nadel M.R., Seeff L.C., White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012, 21(6):895-904.
13. Rockhill B., Newman B., Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88(1):15-19.
14. U.S. Census Bureau. National Population Projections 2000; Available from: [accessed January 2013]. http://www.census.gov/population/www/projections/downloadablefiles.html.
15. Berkeley Mortality Database. Lifetables by Year of Birth 1900-2000. Available from: [accessed January 2013]. http://www.demog.berkeley.edu/%7Ebmd/states.html.
16. Muto T., Bussey H.J., Morson B.C. The evolution of cancer of the colon and rectum. Cancer 1975, 36(6):2251-2270.
17. DiSario J.A., Foutch P.G., Mai H.D., Pardy K., Manne R.K. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991, 86(8):941-945.
18. Johnson D.A., Gurney M.S., Volpe R.J., Jones D.M., VanNess M.M., Chobanian S.J., et al. Aprospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990, 85(8):969-974.
19. Koretz R.L. Malignant polyps: are they sheep in wolves' clothing?. Ann Intern Med 1993, 118(1):63-68.
20. Lieberman D.A., Smith F.W. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991, 86(8):946-951.
21. Surveillance, Epidemiology, and End Results (SEER) Program () SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2013 Sub (1973-2011) -linked to county attributes-total U.S., 1969-2012 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission. http://www.seer.cancer.gov.
22. Cancer Intervention and Surveillance Modeling Network (CISNET). Colorectal Cancer Model Profiles. National Cancer Institute. Available from: [accessed January 2013]. http://cisnet.cancer.gov/colorectal/profiles.html/.
23. van Hees F., Habbema J.D., Meester R.G., Lansdorp-Vogelaar I., van Ballegooijen M., Zauber A.G. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 2014, 160(11):750-759.
24. Centers for Disease Control and Prevention. National Health Interview Survey. Available from: [accessed March 2014]. http://www.cdc.gov/nchs/nhis.htm.
25. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149(9):627-637. U. S. Preventive Services Task Force.
26. Lieberman D.A., Rex D.K., Winawer S.J., Giardiello F.M., Johnson D.A., Levin T.R., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143(3):844-857.
27. Atkin W.S., Edwards R., Kralj-Hans I., Wooldrage K., Hart A.R., Northover J.M., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010, 375(9726):1624-1633.
28. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348(9040):1472-1477.
29. Mandel J.S., Church T.R., Ederer F., Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. JNatl Cancer Inst 1999, 91(5):434-437.
30. Jorgensen O.D., Kronborg O., Fenger C. Arandomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002, 50(1):29-32.
31. National Cancer Institute. Age-Specific U.S. Death Rates, 2006-2010. Available from: [accessed April 2014]. http://seer.cancer.gov/archive/csr/1975_2010/browse_csr.php.
32. U.S. Census Bureau. Population Estimates by age, sex, race and Hispanic origin. Available from: [accessed January 2014]. http://www.census.gov/popest/data/index.html.
33. Nishihara R., Wu K., Lochhead P., Morikawa T., Liao X., Qian Z.R., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. NEngl J Med 2013, 369(12):1095-1105.
34. Schoen C., Osborn R., Squires D., Doty M.M. Access, affordability, and insurance complexity are often worse in the United States compared to ten other countries. Health Aff (Millwood) 2013, 32(12):2205-2215.
35. Gupta S., Sussman D.A., Doubeni C.A., Anderson D.S., Day L., Deshpande A.R., et al. Challenges and possible solutions to colorectal cancer screening for the underserved. JNatl Cancer Inst 2014, 106(4):dju032.
36. U.S. Department of Health and Human Services. Healthcare. Available from: [accessed January 2015]. http://www.hhs.gov/healthcare/index.html.
37. Lee J.K., Levin T.R., Corley D.A. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?. Clin Gastroenterol Hepatol 2013, 11(3):204-207.
38. Levin T.R., Jamieson L., Burley D.A., Reyes J., Oehrli M., Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011, 33(1):101-110.
39. American Cancer Society. The National Colorectal Cancer Roundtable. 2014. Available from: [accessed May 2014]. http://www.cancer.org/healthy/informationforhealthcareprofessionals/colonmdclinicansinformationsource/nationalcolorectalcancerroundtable/national-colorectal-cancer-roundtable.
40. Rauscher G.H., Johnson T.P., Cho Y.I., Walk J.A. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17(4):748-757.
41. Quintero E., Castells A., Bujanda L., Cubiella J., Salas D., Lanas A., et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. NEngl J Med 2012, 366(8):697-706.
42. van Rijn J.C., Reitsma J.B., Stoker J., Bossuyt P.M., van Deventer S.J., Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006, 101(2):343-350.
43. Chung S.J., Kim D., Song J.H., Kang H.Y., Chung G.E., Choi J., et al. Comparison of detection and miss rates of narrow band imaging, flexible spectral imaging chromoendoscopy and white light at screening colonoscopy: a randomised controlled back-to-back study. Gut 2014, 63(5):785-791.
44. Winawer S.J., Zauber A.G., O'Brien M.J., Ho M.N., Gottlieb L., Sternberg S.S., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. NEngl J Med 1993, 328(13):901-906.
45. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. NEngl J Med 1993, 329(27):1977-1981.
46. Gargiullo P.M., Rothenberg R.B., Wilson H.G. Confidence intervals, hypothesis tests, and sample sizes for the prevented fraction in cross-sectional studies. Stat Med 1995, 14(1):51-72.
47. Miettinen O.S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974, 99(5):325-332.
48. Lansdorp-Vogelaar I., van Ballegooijen M., Boer R., Zauber A., Habbema J.D. Anovel hypothesis on the sensitivity of the fecal occult blood test: results ofajoint analysis of 3 randomized controlled trials. Cancer 2009, 115(11):2410-2419.